Rosuvastatin Tablet, Film Coated
Product Images NDC 50090-7482

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Rosuvastatin (NDC 50090-7482). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure-01 (Figure 1)

Figure-01 (Figure 1)
This text appears to be showing results or data from a research study comparing the efficacy of a treatment (RSV) compared to a placebo. The data includes values for the treatment group (RSV) and the placebo group, including the number at risk and the number of years observed. It also provides statistical information such as confidence intervals and p-values.*
FDA Label Image

Figure-02 (Figure 2)

Figure-02 (Figure 2)
The text provides data comparing the effects of Rosuvastatin 20mg versus placebo on various cardiovascular events in a study with 8901 participants. It shows incidence rates and hazard ratios with confidence intervals and p-values for endpoints like major cardiovascular events, cardiovascular death, nonfatal stroke, nonfatal myocardial infarction, and hospitalized unstable angina. The study also includes details about arterial revascularization and how cardiovascular death was defined in the analysis.*
FDA Label Image

Figure-02 (Figure 3)

FDA Label Image

Label Image (Lbl500907482)

FDA Label Image

Structural Formula (Rosuvastatin Str)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.